FIRDAPSE 10 mg, tablet tablet
Active ingredients: Amifampridine, Amifampridine phosphate
Commercialized according to BDPMDispensing in France: Prescription only
Tablettabletorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- FIRDAPSE 10 mg, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) aluminium PVC PVDC de 100 * 1 comprimé(s)
- Marketing authorisation holder
- SERB (BELGIQUE)
- Reimbursement according to BDPM
- 100%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 24 Jun 2010
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
69935992CIP73471556CIP133400934715563Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PHOSPHATE D'AMIFAMPRIDINEcomprimé | 18,98 mg · un comprimé | SA |
| AMIFAMPRIDINEcomprimé | 10 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.